Company Overview of Appistry Inc.
Appistry Inc. provides analytics and data management solutions to corporations, Fortune 100 companies, and government agencies worldwide. It offers Ayrris, an open, scalable solution for data-intensive applications. The company also provides AYRRIS/BIO–NGS Analytics that employs analytical pipelines designed to automate the analysis and management of specific types of data; and AYRRIS/BIO–Data Management, which provides data management solutions adapted to support NGS Analytics for the life sciences sector. In addition, it offers Ayrris/DEFENSE that offers high-volume data ingest, storage, analysis, and delivery for the intelligence and defense organizations; and Ayrris/FINANCE delivers high...
10845 Olive Boulevard
St. Louis, MO 63141
Founded in 2001
Key Executives for Appistry Inc.
Compensation as of Fiscal Year 2013.
Appistry Inc. Key Developments
Appistry Expands Genetic Analysis Offerings Powered by Broad Institute Tools
Dec 2 13
Appistry Inc. announced the expansion of its Cancer Genome Analysis (CGA) Suite to include additional tools for next-generation sequencing (NGS) analysis from the Broad Institute. The first addition to the suite is a method for estimating contamination levels in cancer genome data. The expanded partnership--coming just over one year after the Broad Institute named Appistry as the authorized distributor of the Genome Analysis Toolkit (GATK)--demonstrates the organizations' commitment to developing and delivering high quality genetic analysis algorithms and tools suited to the rigors of regulated clinical sequencing workflows.
Appistry Launches Cancer Genome Analysis Tools
Aug 1 13
Appistry Inc. has launched an integrated suite of tools for analyzing next-generation sequencing, or NGS, cancer genome data. In particular, the Cancer Genome Analysis Suite contains a tool engineered to provide the high sensitivity required for identifying low-frequency point mutations, hard-to-find discrepancies in DNA sequences that are a genetic hallmark of tumor development and evolution. Appistry's Cancer Genome Analysis Suite features two leading genetic analysis tools from the Broad Institute: the Genome Analysis Toolkit (GATK), which Appistry has distributed since October 2012, and MuTect, the Broad Institute's exclusive method for identifying somatic point mutations. MuTect is able to identify mutations occurring in a low fraction of alleles (at or below 0.1; most genetic analysis tools rely on models predicated on a fraction of 0.25 or higher). MuTect's false positive rate
was also significantly lower than competitive tools for identifying somatic point mutations. In addition to MuTect and the GATK, Appistry's Cancer Genome Analysis Suite includes additional tools for somatic mutation studies, such as a tool for identifying somatic indels. The suite also includes an Appistry-built test dataset, results summary, and Perl script that runs all of the tools in the suite across the test dataset or a customer's own data.
LifeMap Sciences, Inc. Announces Partnership with Appistry Inc
Apr 23 13
LifeMap Sciences, Inc. announced a collaborative partnership and value-added reseller agreement with Appistry, Inc., which provides big-data computing that supports life-science and medical analytics at hospitals and medical research centers and organizations. The intent of the partnership is to integrate LifeMap's GeneCards(R) and MalaCards databases of human genes and diseases into the DNA and RNA sequence analysis outputs and reports produced by Appistry's leading-edge Ayrris(TM) computing environment. Appistry will market reports that include the GeneCards(R) and MalaCards data to clinicians and researchers under a revenue share arrangement with LifeMap, based on sales of such reports.
Similar Private Companies By Industry
Recent Private Companies Transactions
August 30, 2013